News

LifeMD, Inc. Investors: Important Class Action Notice

LifeMD, Inc. Investors: Important Class Action Notice

LifeMD, Inc. Class Action Overview

Attention shareholders of LifeMD, Inc. (NASDAQ: LFMD)! The Gross Law Firm has issued an important notice concerning a pending class action lawsuit that could directly impact you. This notice serves to inform investors of the significant details surrounding the lawsuit, including deadlines and recommended actions.

Details of the Class Action Lawsuit

The lawsuit involves allegations against LifeMD, Inc. that stem from numerous misleading statements made by its executives. Shareholders who purchased shares between specific dates may have valid claims. If you bought shares during the designated class period, it is imperative to get in touch for potential lead plaintiff appointments. Do note, however, that participation as a lead plaintiff is not a requirement for recovery.

Class Period and Deadlines

The class period for the lawsuit is defined from May 7, 2025, to August 5, 2025. During this timeframe, it is alleged that LifeMD's management made false statements regarding the company's competitive position and performance, which misled investors about the financial health of the company.

Shareholders are encouraged to register their information promptly to ensure participation in any potential recovery efforts. The crucial deadline for registering in this lawsuit is October 25, 2025. Ensure you do not miss this opportunity, as timely registration is essential.

Nature of Allegations

Details surrounding the allegations highlight three main points. Firstly, the complaint asserts that LifeMD significantly overstated its competitive position in the market. Secondly, it claims that the management irresponsibly increased LifeMD's guidance for 2025 without adequately addressing escalating customer acquisition costs associated with their RexMD segment and the sales of obesity treatments like Wegovy and Zepbound. Finally, these misleading statements led to an artificial inflation of LifeMD's stock, causing investors to experience significant losses.

Next Steps for Shareholders

Once you register as a shareholder of LFMD during the class period, you will gain access to portfolio monitoring software which will keep you informed of the lawsuit’s progress. It’s important to understand that there is no cost or obligation to participate in this lawsuit.

Why Choose Gross Law Firm?

Gross Law Firm is dedicated to upholding investor rights against deceptive practices. As a well-known class action law firm, they strive to hold corporations accountable for fraudulent actions. Their mission aims to assist investors in recovering losses caused by misleading statements and corporate irresponsibility. By partnering with a firm like Gross Law, investors can feel assured they have expert representation dedicated to their cause.

Contact Information

If you have further questions or wish to get involved, you can reach out directly to the Gross Law Firm:

Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action about?

The class action pertains to allegations against LifeMD for issuing misleading statements that affected investors' decisions.

Who can participate in the class action?

Shareholders who bought LFMD shares during the class period can register for potential recovery.

What is the deadline to register?

The deadline to register for the class action lawsuit is October 25, 2025.

What does registering entail?

Registration involves providing information to ensure investors are included in any recovery efforts from the lawsuit.

Why is it important to participate?

Participation is key to potentially recovering losses incurred due to misleading business practices by LifeMD.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Anticipated Growth in Global Animal Feed Market Through 2028

Updated Category News Views 48

Expected Growth in the Global Animal Feed Market Through 2028 The global animal feed market is set for significant growth, with projections indicating an increase of USD 134.4 billion from 2024 to 2028. This remarkable expansion is driven by rising investments and advancements in production capabilities. Experts predict that the market will experience a compound annual...

Continue Reading
DIAGNOS Secures $2 Million in New Financing Led by Centurion One

Updated Category News Views 140

DIAGNOS Engages Centurion One Capital for Private Placement In a significant move, DIAGNOS Inc. is excited to announce its collaboration with Centurion One Capital Corp. as the exclusive lead agent for a brokered private placement. This initiative aims to raise around $2 million through the sale of up to an impressive 6,666,667 units of DIAGNOS at a set issue price of...

Continue Reading
First Quantum Minerals Achieves Resilience in Q4 2024

Updated Category News Views 370

First Quantum Minerals Reports Fourth Quarter Results (In United States dollars, except where noted otherwise) First Quantum Minerals Ltd. (TSX: FM) recently disclosed its financial performance for the fourth quarter of 2024, highlighting a net income of $99 million, equating to $0.12 earnings per share, along with adjusted earnings of $31 million or $0.04 per share....

Continue Reading
Markel Appoints Jamie Mullarkey as Global Officer for Underwriting

Updated Category News Views 51

Markel Welcomes Jamie Mullarkey Markel, a key player in the insurance industry, has made a noteworthy advancement by appointing Jamie Mullarkey as the Global Executive Underwriting Officer for Property and First Party Lines. This strategic decision underscores the company's dedication to leadership and innovation within its insurance operations. The Vision Behind the...

Continue Reading
eToro Announces Impressive Q3 2025 Results and Future Goals

Updated Category News Views 236

eToro Reports Strong Financial Growth for Third Quarter Leading trading and investing platform, eToro Group Ltd. (NASDAQ: ETOR), recently shared its promising financial performance for the third quarter. The report reveals that Net Contribution surged by an impressive 28% year-over-year, reaching $215 million, while Assets Under Administration rose a staggering 76% to hit...

Continue Reading